Cargando…
Pulse oximetry screening for clinically unrecognized critical congenital heart disease in the newborns
AIM: To determine the incidence of clinically unrecognized critical congenital heart disease (CCHD) in the newborns by using pulse oximetric screening. METHODS: Pulse oximetry was performed on clinically normal newborns at 24-48 hours of age. If screening oxygen saturation (SpO(2)) was below 95%, ec...
Autores principales: | Ruangritnamchai, C, Bunjapamai, W, Pongpanich, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232575/ https://www.ncbi.nlm.nih.gov/pubmed/22368668 |
Ejemplares similares
-
Newborn pulse oximetry screening for critical congenital heart defects
por: Jullien, Sophie
Publicado: (2021) -
An update work of pulse oximetry screening for detecting critical congenital heart disease in the newborn
por: Taksande, A, et al.
Publicado: (2017) -
Pulse oximetry screening: a review of diagnosing critical congenital heart disease in newborns
por: Engel, Melissa S, et al.
Publicado: (2016) -
Pulse oximetry as a screening test for congenital heart disease in newborns
por: Janjua, Dalwinder, et al.
Publicado: (2022) -
Cost-effectiveness analysis of newborn pulse oximetry screening to detect critical congenital heart disease in Colombia
por: Londoño Trujillo, Dario, et al.
Publicado: (2019)